Clinical Trial Update: Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-based Therapy

View source ↗

Summary

This clinical trial update notes the incidence of nausea and vomiting in colorectal cancer patients receiving irinotecan-based therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc. | Conditions: Colorectal Cancer | Status: COMPLETED